FLNA
Filana Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.99
+0.04 ▲ +2.05%
🌙 3월 13일 6:56 PM ET (한국 3/14 07:56)
$2.02
+0.03 ▲ +1.51%
| Index | - | P/E | - | EPS (ttm) | -1.88 | Insider Own | 11.72% | Shs Outstand | 0.05B | Perf Week | -1.97% |
| Market Cap | 0.10B | Forward P/E | - | EPS next Y | - | Insider Trans | 9.49% | Shs Float | 0.04B | Perf Month | -7.44% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | -0.23 | Inst Own | 28.56% | Short Float | 16.33% | Perf Quarter | -38.96% |
| Income | -0.09B | P/S | - | EPS this Y | 45.74% | Inst Trans | -0.08% | Short Ratio | 8.11 | Perf Half Y | -7.87% |
| Sales | 0.00B | P/B | 1.29 | EPS next 5Y | - | ROA | -65.95% | Short Interest | 6.96M | Perf YTD | 0.51% |
| Book/sh | 1.54 | P/C | 1.01 | EPS past 3/5Y | 0.23% -50.67% | ROE | -82.66% | 52W High | -60.04% ($4.98) | Perf Year | -23.75% |
| Cash/sh | 1.98 | P/FCF | - | Sales past 3/5Y | - | ROIC | -122.27% | 52W Low | 73.04% ($1.15) | Perf 3Y | -92.23% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -327.51% | Gross Margin | - | Volatility(W/M) | 8.99% 6.91% | Perf 5Y | -96.28% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.16 | Perf 10Y | -85.93% |
| Dividend Ex-Date | 2012/12/13 | Quick Ratio | 2.23 | EPS Q/Q | 54.76% | Profit Margin | - | RSI (14) | 44.14 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.23 | Sales Q/Q | - | SMA20 | -8.42% ($2.17) | Beta | -0.78 | Target Price | $8 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | -5.93% ($2.12) | Rel Volume | 0.68 | Prev Close | $1.95 |
| Employees | 20 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 13.33% - | SMA200 | -20.81% ($2.51) | Avg Volume(3M) | 0.86M | Price | $1.99 |
| IPO | 2000/7/14 | Option/Short | Yes/Yes | Trades | 1808 | Volume | 580,196 | Change | 2.05% |
뉴스 로딩 중...